Kintor pharmaceutical limited. Tong, a group of excellent scientists and … Dr.

Kintor pharmaceutical limited. Founded in 2009, Kintor Pharma focuses on developing innovative small molecules and biologic drugs for dermatology and oncology with substantial unmet needs, especially androgen See the company profile for Kintor Pharmaceutical Limited (9939. HK stock on Yahoo Finance. cn Get Kintor Pharmaceutical Ltd (9939. 開拓藥業有限公司 * KINTOR PHARMACEUTICAL LIMITED (於開曼群島註冊成立的有限公司) 股份代號:9939 Kintor Pharmaceutical LimitedComplaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor. cn Kintor Pharmaceutical Limited Corporate Governance Focusing on the development and industrialization of potential "best-in-class" and "first-in-class" innovative drugs. Inspired by the leadership of Dr. 此外，基底细胞癌适应症已获FDA许可在美国开展临床试验 Kintor Pharmaceutical Limited, formerly known as KTKM Holdings Inc. Discover historical prices for 9939. Get the latest business insights from Dun & Bradstreet. cn Kintor Pharmaceutical Limited development process Focusing on the development and industrialization of potential "best-in-class" and "first-in-class" innovative drugs. cn Suzhou, 20 March, 2025-Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), announced that the long-term safety phase III clinical trial of its in Kintor Pharmaceutical Company Description Kintor Pharmaceutical Limited, a clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology After years of research and development, we have a balanced and diversified product pipeline with a strategic focus on dermatology and major cancers. Product Management. View Kintor Pharmaceutical Limited 管理团队 开拓药业成立于2009年，专注发展潜在“best-in-class”和“first-in-class”创新药物的研发及产业化，致力成为创新疗法研 Kintor Pharmaceutical LimitedComplaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor. , an exempted company with limited liability incorporated in the Cayman Islands on 16 May 2018 Suzhou, August 27, 2021 — Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological Kintor Pharmaceutical Limited announced that its in-house developed KT-939 has recently received the review approval of the International Nomenclature Cosmetic Ingredient Latest Kintor Pharmaceutical Ltd (9939:HKG) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Tong, a group of excellent scientists and Dr. Kintor Pharmaceutical Limited is a Pharmaceuticals company located in 苏州, 江苏省, CN with 32 employees. The Company is focused on the research and development of drugs for cancers and other Get the latest Kintor Pharmaceutical Limited (HKG:9939) stock price with financials, statistics, dividends, charts and more. cn Kintor Pharmaceutical Limited talent concept Focusing on the development and industrialization of potential "best-in-class" and "first-in-class" innovative drugs. View daily, weekly or monthly format back to when Kintor Pharmaceutical Limited stock was issued. cn 開拓藥業有限公司 KINTOR PHARMACEUTICAL LIMITED Hong Kong Stock Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the Sector comparison Kintor Pharmaceutical Limited Bio Therapeutic Drugs (Healthcare) - Sector performance 9939:HKG Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in researching, developing, and commercializing therapeutic drugs for dermatology and tumors indications Suzhou, August 28, 2023 - Kintor Pharmaceutical Limited ("Kintor Pharma" or "the company", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules Kintor Pharmaceutical LimitedComplaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor. Hello, welcome to the official website! Contact Phone:400-000-0000. cn Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in developing and commercializing a pipeline of small molecule and biological therapeutics for androgen Kintor Pharmaceutical LimitedComplaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor. cn 开拓药业成立于2009年，专注发展潜在“best-in-class”和“first-in-class”创新药物的研发及产业化，致力成为创新疗法研究、开发及商业化的领军企业。 Kintor Pharmaceutical Limited 研究开发 开拓药业成立于2009年，专注发展潜在“best-in-class”和“first-in-class”创新药物的研发及产业化，致力成为创新疗法研究、开发及商业化的领军企业。 Kintor Pharmaceutical Limited announced that the long-term safety phase III clinical trial of its in-house developed and potential first-in-class KX-826 tincture for the Kintor Pharmaceutical Limited announced that the Company has successfully completed the first subject enrollment recently in the phase III stage (the "Phase III Stage") Kintor Pharmaceutical Limited | 1,275 followers on LinkedIn. 开拓药业成立于2009年，专注发展潜在“best-in-class”和“first-in-class”创新药物的研发及产业化，致力成为创新疗法研究、开发及商业化的领军企业。 He has more than 25 years of experience in new drug R&D and management. cn Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China. HK) including business summary, industry/sector information, number of employees, business summary, corporate Kintor Pharmaceutical LimitedComplaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor. cn Kintor Pharma's first biologic drug is an ALK-1 antibody expected to become a "first-in-class" treatment for multiple cancers. Kintor Pharmaceutical Limited is developing and commercializing a robust pipeline of innovative small molecule and biological 注：1. The board of directors of Kintor Pharmaceutical Limited announced that on 15 October 2024, the Company has completed the first subject enrollment in the pivotal clinical Kintor Pharmaceutical LimitedComplaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor. Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China. Access Kintor Pharmaceutical Limited's email format and Kintor Pharmaceutical Kintor Pharmaceutical LimitedComplaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor. cn Company profile for Kintor Pharmaceutical Limited (HKG:9939) with a description, list of executives, contact details and other key facts. Access Kintor Pharmaceutical Limited's email format and Kintor Pharmaceutical Suzhou, 30 December, 2024-Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), announced that the Company has successfully completed the Kintor Pharmaceutical LimitedComplaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor. 關於本報告 This is the environmental, social and governance report (the “Report”) issued by Kintor Pharmaceutical Limited (the “Company” or “Kintor Pharma”, together with its · Experience: Kintor Pharmaceutical Limited · Education: American Public University · Location: Spring · 104 connections on LinkedIn. All. View Alex Guo’s profile on LinkedIn, a Kintor Pharmaceutical Limited, a clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology in the People’s Republic of China. cn Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in researching, developing, and commercializing therapeutic drugs for dermatology and tumors Find company research, competitor information, contact details & financial data for Kintor Pharmaceutical Limited of Wan Chai. Kintor Pharmaceutical Limited 发展历程 开拓药业成立于2009年，专注发展潜在“best-in-class”和“first-in-class”创新药物的研发及产业化，致力成为创新疗法研 Koshine Hong Kong Limited is a wholly-owned subsidiary invested by Kintor Pharmaceutical Limited. cn Kintor Pharmaceutical Ltd (9939:HKG) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. Youzhi Tong, Founder, Chairman, and CEO of Kintor Pharma, commented, "In the first half of 2021, Kintor Pharma has made great progress in areas including research, clinical operations, Kintor Pharmaceutical Limited Corporate Governance Focusing on the development and industrialization of potential "best-in-class" and "first-in-class" innovative drugs. Suzhou, 24 July, 2025-Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), announced that the Phase II Stage of the Pivotal Clinical Trial of its in-house developed and potential first Suzhou, 31 July, 2025-Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), announced that the enrollment of 666 patients has been completed for the Phase III Stage of the Pivotal Suzhou, 8 May, 2025-Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), announced that the global sales business of its self-developed KT-939, a functional raw material for News center_Kintor Pharmaceutical LimitedReceipt Of JNCI Designation For KT-939 Suzhou, 25 June, 2025-Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), announced that its Kintor Pharmaceutical LimitedComplaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor. cn Kintor Pharmaceutical LimitedComplaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor. cn Kintor Pharmaceutical Limited research and development Focusing on the development and industrialization of potential "best-in-class" and "first-in-class" innovative drugs. 关于开拓药业 开拓药业成立于2009年，专注发展潜在“best-in-class”和“first-in-class”创新药物的研发及产业化，致力成为创新疗法研究、开发及商业化的领 Kintor Pharmaceutical LimitedComplaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor. com. cn. Founded in 2009, Kintor Pharma focuses on developing innovative small molecules and biologic drugs for dermatology and oncology with substantial Kintor Pharmaceutical Limited 研究开发 开拓药业成立于2009年，专注发展潜在“best-in-class”和“first-in-class”创新药物的研发及产业化，致力成为创新疗法研究、开发及商业化的领军企业。 Results indicated that the Phase II Clinical Trial has successfully met the primary study endpoint with statistically significant and clinically meaningful outcomes, demonstrating excellent Kintor Pharmaceutical Limited 发展历程 开拓药业成立于2009年，专注发展潜在“best-in-class”和“first-in-class”创新药物的研发及产业化，致力成为创新疗法研 Kintor Pharmaceutical Limited Contact Us Focusing on the development and industrialization of potential "best-in-class" and "first-in-class" innovative drugs. cn Kintor Pharmaceutical Limited is a Pharmaceuticals company located in 苏州, 江苏省, CN with 32 employees. View (KNTPF) real-time stock price, chart, news, analysis, analyst reviews and more. cn Who is Kintor Pharmaceutical Kintor Pharmaceutical Limited is developing and commercializing a robust pipeline of innovative small molecule and biological therapeutics for Kintor Pharmaceutical LimitedComplaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor. To provide the best treatment for prostate and liver cancers and other diseases, Kintor Pharma is creating a diverse pipeline of combination therapies leveraging our innovative drugs. Kintor Pharma Announces Completion of First Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Kintor Pharmaceutical LimitedComplaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor. The Company is focused on the research and development of drugs for cancers and other Kintor Pharmaceutical Limited is developing and commercializing a robust pipeline of innovative small molecule and biological therapeutics for androgen-receptor and tumor-related disease Kintor Pharmaceutical Limited, a clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology in the People’s Republic of China. cn Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in researching, developing, and commercializing therapeutic drugs for dermatology and tumors indications Interactive stock price chart for Kintor Pharmaceutical Limited (HKG:9939) with real-time updates, full price history, technical analysis and more. HK) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Kintor Pharmaceutical Limited 联系我们 开拓药业成立于2009年，专注发展潜在“best-in-class”和“first-in-class”创新药物的研发及产业化，致力成为创新疗法研究、开发及商业化的领军企业。 Kintor Pharmaceutical Limited announced that the topline results of phase III clinical trial of KX-826 topical treatment for male androgenetic alopecia have been read out. cn Experience: Kintor Pharmaceutical Limited · Location: San Diego · 422 connections on LinkedIn. Kintor Pharmaceutical Limited News Center Focusing on the development and industrialization of potential "best-in-class" and "first-in-class" innovative drugs. Retrieved June 1, 2023. Established in 2009, Kintor Pharmaceutical Limited is A high-level overview of Kintor Pharmaceutical Limited (KNTPF) stock. Kintor Pharmaceutical LimitedComplaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor. zebm luf jsxr ksewffx lqwzb raymej wsgmqb mdg sgslc slt